The Board is organzied a stakeholder working group to develop best practices for making information on prescription drug container labels accessible to people who are blind or visually impaired or who are elderly. This working group will develop best practices for pharmacies on providing independent access to prescription drug container labels. The Board gained the responsibility to address this issue under the "Food and Drug Administration Safety and Innovation Act" which was signed into law in July 2012.
Sign up to receive updates on this initative.
For further information on this rulemaking, contact Susan Crawford:
|mail:||Office of Technical and Information Services, 1331 F Street NW, Suite 1000, Washington, DC 20004-1111|